Mountain Hill Investment Partners Corp. Sells 74,200 Shares of CVS Health Corporation (NYSE:CVS)

Mountain Hill Investment Partners Corp. decreased its position in CVS Health Corporation (NYSE:CVS - Free Report) by 99.4% during the 1st quarter, according to its most recent filing with the SEC. The institutional investor owned 420 shares of the pharmacy operator's stock after selling 74,200 shares during the period. Mountain Hill Investment Partners Corp.'s holdings in CVS Health were worth $28,000 as of its most recent filing with the SEC.

Several other institutional investors have also recently bought and sold shares of the company. Essex Financial Services Inc. increased its holdings in shares of CVS Health by 0.8% during the 1st quarter. Essex Financial Services Inc. now owns 20,705 shares of the pharmacy operator's stock worth $1,403,000 after acquiring an additional 166 shares during the last quarter. McIlrath & Eck LLC lifted its position in shares of CVS Health by 32.6% during the 4th quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator's stock valued at $32,000 after acquiring an additional 174 shares during the period. Sumitomo Life Insurance Co. lifted its position in shares of CVS Health by 1.0% during the 1st quarter. Sumitomo Life Insurance Co. now owns 17,114 shares of the pharmacy operator's stock valued at $1,159,000 after acquiring an additional 174 shares during the period. Koshinski Asset Management Inc. lifted its position in shares of CVS Health by 3.7% during the 1st quarter. Koshinski Asset Management Inc. now owns 4,930 shares of the pharmacy operator's stock valued at $334,000 after acquiring an additional 178 shares during the period. Finally, Horizon Bancorp Inc. IN lifted its position in shares of CVS Health by 7.4% during the 1st quarter. Horizon Bancorp Inc. IN now owns 2,610 shares of the pharmacy operator's stock valued at $177,000 after acquiring an additional 180 shares during the period. Institutional investors own 80.66% of the company's stock.

CVS Health Stock Down 0.6%

Shares of NYSE:CVS opened at $64.36 on Tuesday. The business's 50 day simple moving average is $64.99 and its two-hundred day simple moving average is $62.61. The firm has a market cap of $81.42 billion, a P/E ratio of 15.36, a PEG ratio of 0.93 and a beta of 0.57. The company has a debt-to-equity ratio of 0.77, a quick ratio of 0.63 and a current ratio of 0.82. CVS Health Corporation has a 52-week low of $43.56 and a 52-week high of $72.51.

CVS Health (NYSE:CVS - Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.62 by $0.63. The business had revenue of $94.59 billion for the quarter, compared to analyst estimates of $93.07 billion. CVS Health had a return on equity of 10.59% and a net margin of 1.39%. The company's quarterly revenue was up 7.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.31 earnings per share. As a group, research analysts forecast that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 1st. Investors of record on Tuesday, July 22nd will be paid a dividend of $0.665 per share. The ex-dividend date of this dividend is Tuesday, July 22nd. This represents a $2.66 annualized dividend and a yield of 4.13%. CVS Health's dividend payout ratio is currently 63.48%.

Insider Buying and Selling

In other news, Director Guy P. Sansone acquired 1,570 shares of CVS Health stock in a transaction that occurred on Thursday, June 5th. The stock was bought at an average price of $63.70 per share, with a total value of $100,009.00. Following the completion of the purchase, the director owned 12,007 shares in the company, valued at approximately $764,845.90. The trade was a 15.04% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 1.22% of the company's stock.

Wall Street Analyst Weigh In

CVS has been the subject of several recent analyst reports. Wall Street Zen upgraded CVS Health from a "hold" rating to a "buy" rating in a research report on Friday, May 9th. UBS Group upped their price objective on CVS Health from $67.00 to $71.00 and gave the stock a "neutral" rating in a research report on Friday, May 2nd. Cowen restated a "buy" rating on shares of CVS Health in a research report on Monday, May 5th. Jefferies Financial Group upped their price objective on CVS Health from $74.00 to $80.00 and gave the stock a "buy" rating in a research report on Monday, June 30th. Finally, Piper Sandler increased their target price on CVS Health from $72.00 to $74.00 and gave the company an "overweight" rating in a research report on Friday, March 21st. Two investment analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $75.06.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.